Frequently asked questions - Certification of Cabo Verde as eliminating malaria

The government of Cabo Verde, in December 2021, submitted a formal request to the Director General of WHO for the consideration and certification of malaria elimination, having reported three consecutive years of zero cases of indigenous (local) malaria due to sustained and robust public health measures.

In response, WHO initiated the process for certification of malaria elimination; WHO certification of malaria elimination follows a standard procedure, explained briefly on the webpage and in greater detail in the publication  "Preparing for certification of malaria elimination". This same process is followed for all countries requesting a WHO malaria elimination certification.

  • Cabo Verde is an archipelago located off the coast of West Africa, consisting of ten islands (9 inhabited) and eight islets.
  • It has a resident population of around 483,628   inhabitants and is culturally diverse.
  • Cabo Verde has a diverse terrain and ecology, ranging from a very rugged rocky terrain due to its volcanic origin to relatively flat plains with sandy beaches.
  • Cabo Verde's economy is driven by tourism - which accounts for approximately 25 per cent of GDP

Related link

WHO Certifies Cabo Verde as Malaria-Free, Marking a Historic Milestone in the Fight Against Malaria

Malaria is a life-threatening disease spread to humans by some types of mosquitoes (female Anopheles spp). It is mainly found in tropical countries. It is preventable and curable. The infection is caused by a parasite (Plasmodium spp.) transmitted from person to person by the mosquito. Symptoms can be mild or life-threatening, especially among nonimmune persons with little previous exposure to the illness and in situations where treatment is delayed.

Malaria can be prevented with medicines and by avoiding mosquito bites from potentially infected mosquitoes. Treatments can stop mild cases from getting worse. Blood transfusions may also, in rare instances, transmit malaria parasites, and there are a few cases of neonatal malaria acquired during pregnancy and delivery.

Five (5) Plasmodium parasite species cause malaria in humans, and two (2) species – P. falciparum and P. vivax –pose the greatest threat. P. falciparum is the deadliest malaria parasite and the most prevalent on the African continent. P. vivax is the dominant malaria parasite in most countries outside of sub-Saharan Africa. The other malaria species that can infect humans are P. malariae, P. ovale, and P. knowlesi.